E. Jay Wilusz
Patent Attorney, Attorney at Law
Massachusetts
NJ, WA, Patent Bar
"Easy communication, Very Knowledgeable Attorney!"
About
clients
upcounsel
experience
Practice Areas
Client Reviews
"I had the pleasure to work with this attorney again and would highly recommend. Looking forward to working with him again."
"Very timely responses, detailed work, and excellent ability to narrow the scope of work to be as valuable as possible to my limited budget"
"Great lawyer to work with. He makes sure everything is understood and takes time go through things in detail. Provides great feedback. Looking forward to working with him again in the near future and would highly recommend."
"I was so blessed to have found Jay. He's SUPER kind, patience and helpful in explaining the patent process. Excellent communication. He was always courteous and patience with any questions I had --- and, I had a lot."
"Jay was very responsive and helpful throughout this job. His work was incredibly thorough and I fully intend to work with him on my future IP needs."
"Great experience, would work with again."
Work History
EJW Pharma Strategy LLC
Principal and Founder
Jul 2012 - Present
• Advise pharma companies on business development, IP, regulatory, and licensing strategies.
• Design and implement IP, legal, marketing, business development and regulatory opportunities for Life Science products.
• Completed license deal of multiple products for 400 MM USD for a top 5 global Life Science company.
• Implement new development and marketing plans for Sanofi TB drug, Priftin®.
Sanofi
US Life Cycle Management Oncology and Multiple Sclerosis Franchises Lead
Oct 2010 - Jun 2012
• Led teams of multi-functional experts to develop exclusivity for Aubagio®, Lemtrada®, Jevtana®, and Elitek®, via indications, drug delivery, drug repurposing and adherence projects.
• Appraised biotechnology and asset values for the acquisition of Genzyme.
• Implemented biotech strategy and due diligence for US and EU product development and marketing.
• Negotiated licensing agreement terms.
Novartis Pharmaceuticals
Vice President, Pharma Regions Counsel, No. & So. America & Japan, Pharma IP Dept.
Jun 2001 - Aug 2010
• Obtained product patent protection, asset licenses, IP rights and rendered opinions for products with sales of 15+ Billion USD.
• Successful litigation outcome for products worth 1+ Billion USD.
• Negotiated IP protection and exclusivity with government entities and organizations in US, CA, LatAm and Japan.
• Implemented strategy, initiatives, and financial controls for 25 member IP staff.